Constellation Pharmaceuticals
Signal active
Organization
Contact Information
Overview
Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.
About
Industries
Biotechnology, Pharmaceutical, Medical, Genetics
Founded
2008
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Constellation Pharmaceuticals headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Medical, Genetics sector. The company focuses on Biotechnology and has secured $161.4B in funding across 224 round(s). With a team of 101-250 employees, Constellation Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Constellation Pharmaceuticals, raised $17.2M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
14
Investors
4
Lead Investors
0
Total Funding Amount
$720.5M
Details
10
Constellation Pharmaceuticals has raised a total of $720.5M in funding over 10 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2012 | Late Stage Venture | 95.0M | ||
| 2011 | Early Stage Venture | 15.0M | ||
| 2010 | Early Stage Venture | 22.3M | ||
| 2009 | Early Stage Venture | 17.2M |
Investors
Constellation Pharmaceuticals is funded by 54 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Topspin Partners | - | FUNDING ROUND - Topspin Partners | 55.0M |
| Anthony Evnin | - | FUNDING ROUND - Anthony Evnin | 55.0M |
| Constellation Pharmaceuticals | - | FUNDING ROUND - Constellation Pharmaceuticals | 55.0M |
| Venrock | - | FUNDING ROUND - Venrock | 55.0M |
Recent Activity
There is no recent news or activity for this profile.